Retension Pharmaceuticals, Inc. (RTSN)
NASDAQ: RTSN · Real-Time Price · USD
10.72
-0.88 (-7.59%)
Nov 5, 2026, 4:00 PM EST - Market closed
Retension Pharmaceuticals Market Cap
Retension Pharmaceuticals has a market cap or net worth of $89.31 million as of November 5, 2026. It is the 25,643rd most valuable company in the world and the 4,146th biggest in the United States.
Market Cap
89.31M
Enterprise Value
75.82M
1-Year Change
n/a
Global Rank
Country Rank
#4,146 United States
Category
ChartMarket Cap Chart
Since the IPO on October 9, 2026, Retension Pharmaceuticals's market cap has decreased from $94.58M to $89.31M, a decrease of -5.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 89.31M | -7.55% |
| Nov 4, 2026 | 96.60M | -1.65% |
| Nov 3, 2026 | 98.23M | 4.34% |
| Nov 2, 2026 | 94.15M | -0.53% |
| Oct 30, 2026 | 94.65M | -3.97% |
| Oct 29, 2026 | 98.56M | -9.63% |
| Oct 28, 2026 | 109.06M | -3.18% |
| Oct 27, 2026 | 112.64M | -5.06% |
| Oct 26, 2026 | 118.64M | -6.62% |
| Oct 23, 2026 | 127.06M | -1.61% |
| Oct 22, 2026 | 129.14M | 3.33% |
| Oct 21, 2026 | 124.97M | -7.29% |
| Oct 20, 2026 | 134.81M | -0.92% |
| Oct 19, 2026 | 136.06M | 16.06% |
| Oct 16, 2026 | 117.23M | 15.23% |
| Oct 15, 2026 | 101.73M | 4.90% |
| Oct 14, 2026 | 96.98M | 0.09% |
| Oct 13, 2026 | 96.90M | 2.74% |
| Oct 12, 2026 | 94.31M | -0.28% |
| Oct 9, 2026 | 94.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 94.58M |
| Vivani Medical | 93.81M |
| Tenax Therapeutics | 93.37M |
| Neumora Therapeutics | 91.51M |
| ImmuCell | 90.37M |
| Seer, Inc. | 90.26M |
| Tevogen | 87.50M |
| Cibus | 87.13M |